World Investment Advisors Has $3.90 Million Stock Position in Intuitive Surgical, Inc. $ISRG

World Investment Advisors grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 27.6% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 6,888 shares of the medical equipment provider’s stock after purchasing an additional 1,489 shares during the period. World Investment Advisors’ holdings in Intuitive Surgical were worth $3,901,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Draper Asset Management LLC lifted its position in shares of Intuitive Surgical by 41.9% in the fourth quarter. Draper Asset Management LLC now owns 5,029 shares of the medical equipment provider’s stock worth $2,848,000 after purchasing an additional 1,485 shares in the last quarter. Atlantic Union Bankshares Corp lifted its position in shares of Intuitive Surgical by 19.3% in the third quarter. Atlantic Union Bankshares Corp now owns 22,759 shares of the medical equipment provider’s stock worth $10,179,000 after purchasing an additional 3,676 shares in the last quarter. Valley Wealth Managers Inc. lifted its position in shares of Intuitive Surgical by 52.7% in the third quarter. Valley Wealth Managers Inc. now owns 4,084 shares of the medical equipment provider’s stock worth $1,826,000 after purchasing an additional 1,409 shares in the last quarter. AGF Management Ltd. lifted its position in shares of Intuitive Surgical by 0.6% in the third quarter. AGF Management Ltd. now owns 464,179 shares of the medical equipment provider’s stock worth $207,595,000 after purchasing an additional 2,575 shares in the last quarter. Finally, AE Wealth Management LLC lifted its position in shares of Intuitive Surgical by 18.9% in the third quarter. AE Wealth Management LLC now owns 11,556 shares of the medical equipment provider’s stock worth $5,168,000 after purchasing an additional 1,836 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, SVP Patricia L. Wadors sold 220 shares of Intuitive Surgical stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $499.71, for a total value of $109,936.20. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Mark Brosius sold 2,362 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total transaction of $1,177,882.16. Following the completion of the transaction, the senior vice president directly owned 3,554 shares in the company, valued at approximately $1,772,308.72. This represents a 39.93% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 5,647 shares of company stock valued at $2,760,359. 0.60% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Jefferies Financial Group reduced their price target on shares of Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating for the company in a research report on Wednesday, April 22nd. BTIG Research reissued a “buy” rating and issued a $574.00 price target on shares of Intuitive Surgical in a research report on Wednesday, April 22nd. The Goldman Sachs Group raised their price objective on shares of Intuitive Surgical from $609.00 to $621.00 and gave the company a “buy” rating in a research report on Wednesday, April 22nd. Sanford C. Bernstein raised their price objective on shares of Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a research report on Friday, January 23rd. Finally, Truist Financial cut their price objective on shares of Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating on the stock in a research report on Wednesday, April 15th. Eighteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $581.91.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $428.06 on Friday. The firm has a market cap of $151.60 billion, a PE ratio of 51.89, a PEG ratio of 3.45 and a beta of 1.51. The firm’s 50 day moving average price is $465.23 and its 200 day moving average price is $514.69. Intuitive Surgical, Inc. has a twelve month low of $417.74 and a twelve month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. During the same quarter last year, the firm earned $1.81 earnings per share. The company’s revenue for the quarter was up 23.0% on a year-over-year basis. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.